MAHA Stack

The MAHA Stack — inspired by RFK Jr.''s "Make America Healthy Again" movement and his public advocacy for peptide access — combines three of the most evidence-backed peptides into a foundational health optimization protocol covering healing, immunity, and cognitive function. After RFK''s February 2026 announcement that 14 previously banned peptides would return to legal compounding, this combination became one of the most searched peptide stacks online. BPC-157 provides systemic healing support — gut mucosal repair, connective tissue regeneration, anti-inflammatory action, and neurotropic effects across the gut-brain axis. Its broad mechanism makes it a foundational health compound rather than a specialized treatment. Thymosin Alpha-1 is an immune modulator originally isolated from the thymus gland. Unlike crude immune "boosters," it precisely calibrates immune function — enhancing the response against pathogens and abnormal cells while reducing excessive inflammatory signaling that drives autoimmune-type conditions. It activates dendritic cells, NK cells, and T-helper cells while modulating cytokine production. Thymosin Alpha-1 has FDA-approved use in some countries for hepatitis and is extensively studied for chronic fatigue, autoimmune conditions, and cancer immunotherapy support. Semax adds the cognitive and neural component — BDNF upregulation, dopaminergic support, and neuroprotection. This is consistent with the MAHA movement''s emphasis on brain health and cognitive function as core components of overall health. Together, this stack represents a "whole-system" approach: healing the body''s physical tissue, calibrating immune function, and supporting the brain — the three systems most impacted by modern inflammatory lifestyles.